Velayos, Fernando S <br/><br/>
Pneumocystis carinii pneumonia during maintenance anti-tumor necrosis factor-alpha therapy with infliximab for Crohn's disease.  [electronic resource] 

 -  Inflammatory bowel diseases  Sep 2004 
 - 657-60 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1078-0998 
<br/><br/><label>Standard No.: </label>10.1097/00054725-200409000-00025  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antibodies, Monoclonal--adverse effects<br/>Azathioprine--adverse effects<br/>Crohn Disease--drug therapy<br/>Gastrointestinal Agents--adverse effects<br/>Humans<br/>Immunosuppressive Agents--adverse effects<br/>Infliximab<br/>Male<br/>Pneumonia, Pneumocystis--chemically induced<br/>Treatment Outcome<br/>Tumor Necrosis Factor-alpha